Royalty PharmaRPRX 
$25.23-0.08%24h
-0.08%24h
Global rank1377
Market cap$11.29B
Change 7d-0.79%
YTD Performance-
SP500 benchmark
P/E9.97
P/S4.80
Revenue$2.35B
Earnings$1.70B
Dividend yield3.2%
Main Sector
Healthcare
EPS for Royalty Pharma (RPRX)
Royalty Pharma has an EPS of $2.53. In 2022, the company made an earnings per share (EPS) of $0.1. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for RPRX
-
Value:-
EPS history for Royalty Pharma from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | $2.53 | 2430.00% |
| 2022 | $0.1 | -93.29% |
| 2021 | $1.49 | -40.69% |
| 2020 | $2.51 | - |
View the highest EPS stocks
